Insider Selling: ASP Isotopes (NASDAQ:ASPI) Director Sells $60,654.82 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Duncan Moore sold 11,642 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $5.21, for a total value of $60,654.82. Following the sale, the director owned 1,044,928 shares in the company, valued at $5,444,074.88. This represents a 1.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

ASP Isotopes Price Performance

ASPI stock opened at $5.37 on Monday. The company has a quick ratio of 12.20, a current ratio of 12.23 and a debt-to-equity ratio of 0.77. ASP Isotopes Inc. has a 52-week low of $3.92 and a 52-week high of $14.49. The stock’s 50 day moving average is $5.06 and its two-hundred day moving average is $6.70. The company has a market capitalization of $676.08 million, a PE ratio of -2.51 and a beta of 3.59.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Friday, April 10th. The company reported ($0.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.70). ASP Isotopes had a negative return on equity of 161.55% and a negative net margin of 734.14%.The business had revenue of $33.32 million for the quarter, compared to analysts’ expectations of $2.03 million. Analysts predict that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Institutional Investors Weigh In On ASP Isotopes

A number of institutional investors have recently made changes to their positions in the company. Alyeska Investment Group L.P. increased its holdings in shares of ASP Isotopes by 73.4% in the 4th quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock valued at $26,191,000 after acquiring an additional 2,072,851 shares during the last quarter. Vanguard Group Inc. boosted its position in ASP Isotopes by 37.9% during the 3rd quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock valued at $43,451,000 after purchasing an additional 1,241,024 shares during the period. Rovida Investment Management Ltd boosted its position in ASP Isotopes by 28.1% during the 4th quarter. Rovida Investment Management Ltd now owns 4,100,000 shares of the company’s stock valued at $21,894,000 after purchasing an additional 900,000 shares during the period. UBS Group AG boosted its position in ASP Isotopes by 150.3% during the 4th quarter. UBS Group AG now owns 2,406,457 shares of the company’s stock valued at $12,875,000 after purchasing an additional 1,445,165 shares during the period. Finally, Geode Capital Management LLC boosted its position in ASP Isotopes by 28.0% during the 4th quarter. Geode Capital Management LLC now owns 2,384,066 shares of the company’s stock valued at $12,758,000 after purchasing an additional 521,611 shares during the period. 16.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ASPI. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a report on Tuesday, April 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, ASP Isotopes presently has a consensus rating of “Hold” and an average target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.